| Literature DB >> 31704066 |
Sergey Sidorenko1, Wolfgang Rennert2, Yuri Lobzin3, Nikolay Briko4, Roman Kozlov5, Leila Namazova-Baranova6, Irina Tsvetkova7, Vladimir Ageevets8, Ekaterina Nikitina9, Anastasia Ardysheva10, Alina Bikmieva11, Ekaterina Bolgarova12, Marina Volkova13, Irina Verentsova14, Asiya Girina15, Natalia Gordeeva16, Irina Demko17, Anna Dushchenko18, Galina Evseeva19, Ludmila Zharkova20, Tatyana Yelistratova21, Julia Zakharova22, Natalia Ivakhnishina23, Elena Zubova24, Olga Kalinogorskaya25, Alla Klimashina26, Tatiana Kozeeva27, Angelina Kraposhina28, Olga Krechikova29, Marina Mamaeva30, Elena Nagovitsyna31, Irina Protasova32, Vadislav Semerikov33, Natalia Sokolova34, Irina Soloveva35, Natalia Strelnikova36, Regina Telepneva37, Irina Feldblium38, Galina Kholodok39, Aida Chagaryan40, Nadezhda Sheglinkova41.
Abstract
Russia introduced PCV13 in 2014. We studied the serotype composition of S. pneumoniae isolated from the nasopharynx of healthy children younger than 6 years in St. Petersburg, Smolensk, Perm, Krasnoyarsk, Khanty-Mansiysk and Khabarovsk, between 2016 and 2018. 2.4% of children had completed a 3-dose course of PCV13, while 25.6% had received 1 or 2 doses. Pneumococcal DNA detection by PCR demonstrated S. pneumoniae in 37.2% of samples with regional variation between sites (27.3 to 56.9%). There was little difference between vaccinated, partially vaccinated and un-vaccinated children. Children who had received at least 1 dose of PCV13 had lower carriage rates of vaccine serotypes than their unvaccinated peers (49.9 vs. 61.4%; p < 0.001). Children who had received at least 1 dose of PCV13 showed increased carriage rates of non-vaccine serotypes (50 vs 38.6%; P < 0.001). Especially serogroup 15AF was more prevalent among fully immunized children than among their peers (12.5 vs 2.7%; P < 0.05).Entities:
Keywords: PCV13; Pneumococcal serotypes; Post-vaccination serotype composition
Mesh:
Substances:
Year: 2019 PMID: 31704066 DOI: 10.1016/j.diagmicrobio.2019.114914
Source DB: PubMed Journal: Diagn Microbiol Infect Dis ISSN: 0732-8893 Impact factor: 2.803